NCT00720083 · MORE INFO

Limitations, agreements, and source contact

Chemotherapy and Radiation Therapy (RT) With or Without Vandetanib in Treating Patients With High-Risk Stage III or Stage IV Head and Neck Cancer · Source last updated 2015-11-17

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: This study terminated early with 34 subjects accrued out of 170 planned, therefore no analyses were performed.

point Of Contact

email: wseiferheld@acr.com
organization: Radiation Therapy Oncology Group (RTOG)
title: Wendy Seiferheld

Complete source fields

certain Agreement

pi Sponsor Employee: false
restrictive Agreement: false

limitations And Caveats

description: This study terminated early with 34 subjects accrued out of 170 planned, therefore no analyses were performed.

point Of Contact

email: wseiferheld@acr.com
organization: Radiation Therapy Oncology Group (RTOG)
title: Wendy Seiferheld

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice